Healthcare Services

Gastric Ulcer Market: Drivers and Future Outlook

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Gastric Ulcers Market Progress Between 2026 And 2030?

The gastric ulcers market has experienced substantial growth in recent years. It is anticipated to expand from $4.53 billion in 2025 to $4.78 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.5%. The expansion observed in the historic period can be ascribed to the prevalence of h pylori infection, the widespread use of antacids, the availability of antibiotics, hospital-based GI treatments, and the increasing adoption of endoscopic diagnosis.

The market for gastric ulcers is projected to experience consistent expansion over the upcoming years, reaching a valuation of $5.78 billion by 2030, driven by a compound annual growth rate (CAGR) of 4.9%. This anticipated expansion throughout the forecast period stems from factors such as the creation of sophisticated acid-suppression medications, the need for enduring ulcer management, a rise in outpatient services, enhancements in diagnostic tools, and an uptick in conditions linked to lifestyle. Key developments foreseen during this period encompass a greater reliance on proton pump inhibitors, a heightened emphasis on eradicating Helicobacter pylori, an increase in integrated drug treatments, the broadening of non-invasive diagnostic approaches, and a greater understanding of gastrointestinal ailments.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

What Significant Factors Are Influencing The Gastric Ulcers Market Expansion?

The expanding geriatric population is anticipated to stimulate the growth of the gastric ulcers market moving forward. The geriatric population refers to individuals generally 65 years and older, who are characterized by particular health considerations linked to aging. The growth in this demographic is attributed to advancements in healthcare, which contribute to longer life expectancies, alongside declining birth rates observed globally in numerous regions. Gastric ulcers are frequently found in the elderly, primarily due to increased consumption of NSAIDs and diminished mucosal protection, which often elevates the risk of complications. For instance, in January 2024, the Population Reference Bureau (PRB), a US-based private non-profit organization, projected that the population of Americans aged 65 and older will surge from 58 million in 2022 to 82 million by 2050, indicating a 47% increase. Additionally, this age group’s proportion of the total population is expected to rise from 17% to 23%. Consequently, the increasing geriatric population is a primary force driving the expansion of the gastric ulcers market.

Which Segment Categories Are Included In The Gastric Ulcers Market Segment Analysis?

The gastric ulcers market covered in this report is segmented –

1) By Drug Class: Proton Pump Inhibitors (PPI), H2 Antagonists, Antacids, Antibiotics, Cytoprotective Agents, Other Drug Classes

2) By Diagnosis: Stool Test, Endoscopy, Imaging Tests, Computed Tomography (CT) Scan, X-ray, Blood Tests, Other Diagnosis

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End Users

Subsegments:

1) By Proton Pump Inhibitors (PPI): Omeprazole, Lansoprazole, Pantoprazole, Esomeprazole, Rabeprazole

2) By H2 Antagonists: Ranitidine, Famotidine, Cimetidine, Nizatidine

3) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide, Sodium Bicarbonate

4) By Antibiotics: Amoxicillin, Clarithromycin, Metronidazole, Tetracycline

5) By Cytoprotective Agents: Sucralfate, Misoprostol, Bismuth Subsalicylate

6) By Other Drug Classes: Prostaglandin Analogues, Prokinetic Agents, Herbal And Alternative Medications, Combination Therapies

What Trends Are Affecting The Direction Of The Gastric Ulcers Market?

Leading companies within the gastric ulcer market are concentrating on developing innovative products, such as new formulations of drugs, to improve treatment effectiveness and lessen adverse reactions. New formulation drugs are medications designed with novel combinations of active ingredients, delivery systems, or dosage forms to enhance their efficacy, safety, and patient adherence. For instance, in June 2024, Akums Drugs and Pharmaceuticals Ltd., an India-based pharmaceutical preparation manufacturing company, launched Rabeprazole + Levosulpiride SR Capsules. These capsules were introduced to provide superior relief for conditions including gastro-oesophageal reflux disease (GERD) and other gastrointestinal tract (GIT) disorders. The products integrate a proton pump inhibitor and a prokinetic agent, proving effective in treating gastrointestinal ailments like gastroesophageal reflux disease (GERD) and gastric ulcers. This specific formulation both lowers gastric acid secretion and boosts gastric motility, offering complete symptom relief from issues such as heartburn and indigestion.

Who Are The Active Companies Shaping The Gastric Ulcers Market?

Major companies operating in the gastric ulcers market are Pfizer Inc., Merck & Co Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd, Boehringer Ingelheim, Viatris Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd, Cadila Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Yuhan Corporation, Daewoong Pharmaceutical Co. Ltd, Cadila Healthcare Ltd, Novitium Pharma LLC

Get The Full Gastric Ulcers Market Report:

https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

Which Region Is The Leading Market For The Gastric Ulcers Market?

North America was the largest region in the gastric ulcers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Gastric Ulcers Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

Browse Through More Reports Similar to the Global Gastric Ulcers Market 2026, By The Business Research Company

Duodenal Ulcer Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/duodenal-ulcer-treatment-global-market-report

Peptic Ulcer Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptic-ulcer-global-market-report

Pressure Ulcers Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/pressure-ulcers-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795